BULETIN PENYELIDIKAN DAN

PEMBANGUNAN (R&D) FARMASI NEGERI

SELANGOR BIL. 1/2018

JAWATANKUASA R&D FARMASI SELANGOR 2018

PENASIHAT

PN. AKMALYATUN KAMAL BT KAMARUDDIN

TIMBALAN PENGARAH

Cawangan A&P Farmasi BPF, JKN

Selangor

PENGERUSI PN. NORHALINA BT SULAIMAN Pegawai Farmasi UF54

PKD Klang

SETIAUSAHA I PN. HAFIZAH BT. HASSIM Peg.Farmasi UF44 PKD Hulu Selangor

SETIAUSAHA II PN HANIATI BT HASAN Ketua Pen. Pengarah (A&P) UF52

BPF, Jabatan Kesihatan Negeri Selangor

AHLI JAWATANKUASA R&D FARMASI SELANGOR 2018

JK KECIL SAINTIFIK

Ruwaida Nur bt Zainol Abidin Peg.Farmasi UF52 Hosp Serdang

Dr. Wardati bt Mazlan Kepli Peg.Farmasi UF52 Hosp Serdang

Chong Pei Feng Peg.Farmasi UF52 Hosp Sg Buloh

Josephine a/l Henry Basil Peg.Farmasi UF52 Hosp Shah Alam

Wan Nor Ashikin bt Wan Ibrahim Ketua Pen. Pengarah Kanan UF52 BPFJKNS

Sarah Diyana bt Shafie Peg.Farmasi UF52 Hosp Kajang

Kong Su Shan Peg.Farmasi UF52 Hosp Ampang

Nur Kamalah bt Daud@Mahusain Peg.Farmasi UF52 PKD Hulu Langat

Mogana a/p Mathayena Peg.Farmasi UF44 Hosp Selayang

Puteri Juanita bt Zamri Peg.Farmasi UF52Hosp Selayang

JK KECIL LATIHAN

Asmahani bt Ramelan Peg.Farmasi UF52 HTAR

Wong Su Li Peg.Farmasi UF44 PKD Klang

Jaya Mania Rao a/l Ramadoo Peg.Farmasi UF44 Hosp Kuala Kubu Bharu

Teh Wen Yan Peg.Farmasi UF48 HTAJ

Silambarasu a/l Karuppiah Peg.Farmasi UF44 PKD Sabak Bernam

Yah Xin Yun Pen.Pengarah Kanan Farmasi UF44 BPFJKNS

Cindy Fow Peg.Farmasi UF48 Hosp Banting

Dinesh a/l Widiadharan Peg.Farmasi UF48 Hosp Sg Buloh

Puteri Siti Sofiah bt Abdul Aziz Peg. Farmasi UF44 Hosp Ampang

Tan Shirlyn Peg. Farmasi UF48 HTAR

JK KECIL PENERBITAN

Nurul Syazwani binti Mohamad Peg.Farmasi UF44 PKD Kuala Langat

Kwek Lih Ling Peg.Farmasi UF44 Hosp Tanjung Karang

Hazwani bt Harith Peg.Farmasi UF44 Hosp Orang Asli Gombak

Sayeeda Zainab bt Hasnor Peg.Farmasi UF48 PKD Kuala Selangor

Lee Zhe Yen Peg.Farmasi UF44 PKD Gombak

Kua Kok Pim Peg.Farmasi UF48 PKD Petaling

Hafizah bt Hassim Peg.Farmasi UF44 PKD Hulu Selangor

Norfaradila bt Mohamed Peg.Farmasi UF44 PKD Sepang

SENARAI AHLI

JAWATANKUASA 1

PENCAPAIAN KAJIAN R&D

FARMASI SELANGOR

JAN-DIS 2017 2

AKTIVITI R&D DI PTJ

JAN — JUN 2018 6

PROGRAM AKAN

DATANG 7

ISI KANDUNGAN:

PENCAPAIAN KAJIAN R&D

FARMASI SELANGOR

JAN-JUN 2018 3

AKTIVITI JK R&D

FARMASI SELANGOR

JAN — JUN 2018

4-5

PENCAPAIAN KAJIAN R&D FARMASI NEGERI SELANGOR JAN-DIS 2017

STATUS KAJIAN SAINTIFIK SELANGOR 2017

BILANGAN KAJIAN SAINTIFIK SELANGOR YANG DIBENTANGKAN DI

PERSIDANGAN 2017

PENCAPAIAN KAJIAN R&D FARMASI NEGERI SELANGOR JAN-JUN 2018

Fiqri R., Maisarah A. A., S. Yeng Zheng, Y. Pei Qi,

Dr. Wardati M. K., H. Yee Yin, T. Jia Yee.

Hosptial Serdang

Introduction - Antiplatelet (AP) is normally prescribed for secondary prevention of cardiovascular (CV) disease such as

the patients with history of acute coronary syndrome (ACS) following percutaneous coronary intervention (PCI), but

not for primary prevention as it is not routinely recommended. The aim of this study is to assess the clinical out-

comes post-PCI in patient with prior antiplatelet therapy (PAP) and without PAP, as no previous study was done.

Methods - List of patients who had undergone PCI in 2015-2016 were obtained from Invasive Cardiac Lab. Baseline

characteristics, types of ACS, clinical outcomes post-PCI were extracted from electronic Hospital Information System

(eHIS), followed by recording in case report form. Risk of CV events post-PCI was studied for both groups (PAP and

without PAP) using logistic regression analysis, and adjusted for age and gender.

Results - A total of 227 patients were included in this study. Of them, 25.6% of patients had PAP while 72.2% without

PAP. 10 (4.5%) patients experienced CV events post-PCI, and it is statistically insignificant between PAP and without

PAP groups (5.2% vs 4.3%; p-value = 0.776). In addition, PAP did not significantly lower the risk of CV events

(odds ratio (OR) = 0.80; 95% confidence interval (CI) = 0.20 - 3.20); p-value = 0.749). When it is adjusted to age and

gender, there is an increased risk of CV events but it is not statistically significant (adjusted OR = 1.22; 95% CI =

0.30 - 4.94; p-value = 0.774).

Conclusion - In patients who suffered ACS and had undergone PCI, PAP was not associated with a lower risk of cardi-

ovascular events than without PAP. However, this is a small retrospective analysis and future prospective trials will

be needed.

NMRR-17-1166-35048

PRIOR ANTIPLATELET THERAPY AND CLNICAL OUTCOMES

AFTER PERCUTANEOUS CORONARY INTERVENTION

BEST ORAL PRESENTER

INTERNATIONAL CONFERENCE ON PHARMACY

PRACTICE 2018

27-28 JUN 2018

HOTEL CONCORDE, SHAH ALAM

PENCAPAIAN KAJIAN R&D FARMASI NEGERI SELANGOR JAN-JUN 2018

AKTIVITI DAN LATIHAN JK R&D FARMASI SELANGOR JAN-JUN 2018

AKTIVITI DAN LATIHAN JK R&D FARMASI SELANGOR JAN-JUN 2018

Bengkel Poster & Oral Presentation Tarikh ;

14 Mei 2018 Tempat ; Bilik Mesyuarat Cempaka, Wisma MBSA, Shah Alam Penceramah ; Dr. Kalaiarasu M. Peariasamy Head, Clinical Research Centre, Hospital Sungai Buloh, Objektif ; Memberi pendedahan kepada para pegawai farmasi yang terlibat dalam bidang

Hospital Kajang

Aktiviti R&D : Bengkel Penulisan Manuskrip dan Publication

Tarikh:30-31/10/2017

Penceramah: En. Chan Huan Keat, Pegawai Farmasi U48,

Pusat Penyelidikan Klinikal (CRC) Hospital Sultanah Bahiyah

Hospital Selayang

1) Aktiviti R&D : Basic Study Design Workshop

Tarikh: 13/2/2017

Penceramah: Puteri Juanita, Nurah Zainal Abidin, Lee Chee Ming

2) Aktiviti R&D : Research Proposal Presentation Day

Tarikh: 21/3/2017

Penceramah: Nurakmal Baharum (CRC) ,Nadiah Sa’at (CRC),

Dr Neoh Chin Fen

3) Aktiviti R&D : Statistical Analysis Clinic Day (CRC) Session 1

Tarikh: 30/5/2017

Penceramah: Nadiah Sa’at (CRC), Tassha Hilda Adnan (CRC)

4) Aktiviti R&D : Statistical Analysis Clinic Day (CRC) Session 2

Tarikh: 4/7/2017

Penceramah: Nadiah Sa’at (CRC), Tassha Hilda Adnan (CRC)

5) Aktiviti R&D : Annual Presentation Day

Tarikh: 18/11/2017

Penceramah: Dr Norkasihan (KKM), Dr Neoh Chin Fen (UiTM),

Dr Nor Hayati Abu Samah (UiTM), Dr Azyyati Mohd Suhaimi (UiTM)

Hospital Sungai Buloh

Aktiviti R&D : Meeting for Research Updates with CRC HSgB

Tarikh: 13/10/2017

Penceramah: Nicholas Hing Yee Liang (CRC HSgB)

AKTIVITI R&D DI PTJ SELANGOR

DATE CONFERENCE/ACTIVITY VENUE

9th - 11th July

2018

10th National Pharmacy R&D Conference 2018.

“Enhancing Access to Medicines Through Value-Based

Approaches”

Royale Chulan Hotel,

Seremban

30th August

2018 HKL Research Day Hospital Kuala Lumpur

3th - 7th

September

2018 Research Week CRC HTAR

Hospital Tengku Ampuan

Rahimah

19th - 21st

September

2018 Mini Conference R&D 2018 Wisma MBSA, Shah Alam

24th - 25th

September

2018

National Conference for Clinical Research (NCCR) 2018.

“Patient-centered Research: Digital Health” Hotel Istana, Kuala Lumpur

24th - 25th

September

2018

5th Hospital Serdang Pharmacy Conference. “Towards

Effective Pharmaceutical Care Practice” Hospital Serdang

1st - 5th

October 2018 7th Selangor Research Week 2018 Hospital Shah Alam

PROGRAM AKAN DATANG